Reflect ScientificRSCF PB Ratio is 1.60 as of Jun. 24, 2026, which is 64% below its 10-year median of 4.44. The stock has 4 warning signs investors should review. Among 787 Medical Devices & Instruments companies, Reflect Scientific ranks better than 69.12% on this metric.
Reflect Scientific Inc stock PB Ratio (=1.81) is close to 1-year low of 1.66.
The historical rank and industry rank for Reflect Scientific's PB Ratio or its related term are showing as below:
RSCF'
s PB Ratio Range Over the Past 10 Years
Min: 1.33 Med: 4.44 Max: 50
Current: 1.34
During the past 13 years, Reflect Scientific's highest PB Ratio was 50.00. The lowest was 1.33. And the median was 4.44.
RSCF's PB Ratio is ranked better than 69.12% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.04
vs RSCF: 1.34
During the past 12 months, Reflect Scientific's average Book Value Per Share Growth Rate was 13.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 16.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 34.60% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Reflect Scientific was 263.90% per year. The lowest was -74.60% per year. And the median was 16.30% per year.
Back to Basics: PB Ratio
Reflect Scientific (OTCPK:RSCF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Reflect Scientific PB Ratio Related Terms
Reflect Scientific PB Ratio Historical Data
* Premium members only.
The historical data trend for Reflect Scientific's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Reflect Scientific's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Reflect Scientific PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Reflect Scientific's PB Ratio distribution charts can be found below:
* The bar in red indicates where Reflect Scientific's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Reflect Scientific (RSCF) has a PB Ratio of 1.60 as of Jun. 24, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Reflect Scientific and its competitors. This is 64% below median its historical median of 4.44. Over the past decade, Reflect Scientific's PB Ratio has ranged from 1.33 to 50.00. According to the industry distribution chart, Reflect Scientific ranks #243 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 30.9%.
Is Reflect Scientific's PB Ratio too high?
Reflect Scientific's current PB Ratio of 1.60 is 64% below median its 10-year median of 4.44. Over the past 10 years, this metric has ranged from a low of 1.33 to a high of 50.00. The Medical Devices & Instruments industry median PB Ratio is 2.04. Reflect Scientific's value of 1.60 is 21.6% below this industry median. Based on the distribution chart, Reflect Scientific ranks #243 out of 787 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Reflect Scientific's PB Ratio compare to GCTK and CBSC?
According to the Medical Devices & Instruments industry distribution chart, Reflect Scientific ranks #243 out of 787 companies for PB Ratio. This puts Reflect Scientific in the upper half of its industry. The industry median PB Ratio is 2.04. Reflect Scientific's value of 1.60 is 21.6% below this benchmark. Historically, Reflect Scientific's own PB Ratio has ranged from 1.33 to 50.00 over the past decade. While the company's 10-year median is 4.44 vs. the industry median of 2.04, Reflect Scientific has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.04, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Reflect Scientific's current PB Ratio of 1.60 is 21.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Reflect Scientific and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Reflect Scientific's current PB Ratio is 1.60, which is 64% below median its own 10-year median of 4.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reflect Scientific stock overvalued right now?
Reflect Scientific (RSCF) has a current PB Ratio of 1.60. The current PB Ratio is 1.60, which is 64% below median its 10-year median of 4.44 and 21.6% below the Medical Devices & Instruments industry median of 2.04. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Reflect Scientific (RSCF), the current PB Ratio is 1.60 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Reflect Scientific Inc is engaged in the manufacture and distribution of products targeted at the life science market. The group's customers include hospitals, diagnostic laboratories, pharmaceutical and biotech companies, cold chain management, universities, government and private sector research facilities, and chemical and industrial companies. Its growing product portfolio includes ultra-low temperature freezers, blast freezers, solvent chillers, and refrigerated transportation in addition to supplying OEM products to the life sciences industry. The group's products are Cryometrix, GCFerrules, and Visacon. It recognizes revenue from the sale of scientific equipment for the life sciences and manufacturing industries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RSCF has been successfully added to your 